-
Oct 30, 2024
Kiora Pharmaceuticals Receives Investigational New Drug Approval to Initiate ABACUS-2, a Phase 2 Clinical Trial of KIO-301 for the Treatment of Retinitis Pigmentosa | KPRX Stock News
Kiora Pharmaceuticals (NASDAQ: KPRX) received regulatory approval to initiate ABACUS-2, a Phase 2 clinical trial for KIO
view more -
Oct 30, 2024
11 Best Supplements for Brain Health
Complexio / Getty Images Brain health is an important part of health for all ages. Maintaining a healthy mind helps you
view more -
Oct 30, 2024
Free Amino Acid Market to Grow by USD 1.26 Billion by 2028, Driven by Rising Health Consciousness and AI Powered Insights, Reports Technavio
Oct 29, 2024, 17:33 ET Share this article NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Report on how AI is driving market tra
view more -
Oct 30, 2024
Study shows vitamin D supplementation doesn’t cut cardiac risk — Harvard Gazette
Outdoor physical activity may be a better target for preventive intervention, says researcher Jacqueline Mitchell BIDMC
view more -
Oct 30, 2024
Study explores efficacy of probiotics in colicky infants
29-Oct-2024 - Last updated on 29-Oct-2024 at 15:57 GMT Data published in the European Journal of Pediatrics indicated t
view more -
Oct 30, 2024
Why Demand for Cold Chain Logistics in Pharmaceuticals is Growing Rapidly - Global Trade Magazine
With an increased focus on temperature-sensitive medications and vaccines, pharmaceutical companies, healthcare faciliti
view more -
Oct 30, 2024
Free Amino Acid Market to Grow by USD 1.26 Billion by 2028, Driven by Rising Health Consciousness and AI Powered Insights, Reports Technavio | | victoriaadvocate.com
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global free amino acid ma
view more -
Oct 30, 2024
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC | NBY Stock News
NovaBay Pharmaceuticals (NYSE American: NBY) announces its board has determined an unsolicited offer from Refresh Acquis
view more -
Oct 30, 2024
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Vertex Pharmaceuticals (VRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it re
view more -
Oct 30, 2024
Best probiotics for 2024: Supplements to improve gut health | The Independent
Symprove is among the few gut health supplements to have been studied in a clinical trial. Research in 2019 gave people
view more -
Oct 29, 2024
MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical fi
view more -
Oct 29, 2024
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals - BioSpace
TAIPEI, Taiwan, Oct. 25, 2024 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), toda
view more
SEND YOUR INQUIRY
SUBMIT